Viral Vector and Plasmid DNA Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Wednesday, May 22, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 21, 2019 /PRNewswire/ --

Viral Vector & Plasmid DNA Manufacturing Market: OverviewThis report analyzes the current and future scenario of the global viral vector & plasmid DNA manufacturing market for the period 2019 to 2027. Increase in prevalence and incidence rates of cancer, genetic disorders and infectious diseases, high unmet needs

in patients with rare disorders, and raised acceptance for comparatively newer treatment options in developing countries are likely to be major drivers of the global viral vector & plasmid DNA manufacturing market during the forecast period.Read the full report: https://www.reportlinker.com/p05775478/?utm_source=PRN The viral vector & plasmid DNA manufacturing market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market.It also provides information and data analysis of the global market with respect to segments based on type, application, disease, end-user, and region.A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section.Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market.The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the viral vector & plasmid DNA manufacturing market.Viral Vector & Plasmid DNA Manufacturing Market: Key SegmentsBased on type, the global viral vector & plasmid DNA manufacturing market has been segmented into lentivirus, adenovirus, adeno-Associated Virus (AAV), plasmid DNA, and others.In terms of application, the global viral vector & plasmid DNA manufacturing market has been divided into gene therapy, vaccinology, and others.Based on disease, the market has been segregated into genetic disorders, cancer, infectious disease, and others.In terms of end-user, the market has been bifurcated into biotech companies and research institutes.The market size and forecast for each of these segments have been provided for the period 2019 to 2027, along with their respective CAGR for the forecast period 2017 to 2027, considering 2018 as the base year.Viral Vector & Plasmid DNA Manufacturing Market: Regional OutlookIn terms of region, the global viral vector & plasmid DNA manufacturing market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2019 to 2027, along with their respective CAGR for the forecast period 2017 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.Companies Mentioned in the ReportThe report also profiles major players operating in the global viral vector & plasmid DNA manufacturing market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include CobraBiologics, Novasep Inc., Cell and Gene Therapy Catapult, Kaneka Eurogentec S.A., FUJIFILM Diosynth Biotechnologies Inc., Spark Therapeutics, Inc. Merck KGaA, uniQure N.V., and Lonza. The global viral vector & plasmid DNA manufacturing market has been segmented as below:Viral Vector & Plasmid DNA Manufacturing Market, by TypeLentivirusAdenovirusAdeno-Associated Virus (AAV)Plasmid DNAOthersViral Vector & Plasmid DNA Manufacturing Market, by ApplicationGene TherapyVaccinologyOthersViral Vector & Plasmid DNA Manufacturing Market, by DiseaseGenetic DisordersCancerInfectious DiseaseOthersViral Vector & Plasmid DNA Manufacturing Market , by End-userBiotech CompaniesResearch InstitutesViral Vector & Plasmid DNA Manufacturing Market, by RegionNorth AmericaU.S.CanadaEuropeU.K.GermanyFranceItalySpainRest of EuropeAsia PacificIndiaChinaJapanAustralia & New ZealandRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaSouth AfricaGCC CountriesRest of Middle East & AfricaRead the full report: https://www.reportlinker.com/p05775478/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/viral-vector-and-plasmid-dna-manufacturing-market---global-industry-analysis-size-share-growth-trends-and-forecast-2019---2027-300854438.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store